Searched for
SAI LIFE SCIENCES
Jatayu vs Ravana epic fight steals the show in Ramayana: Who plays the characters and why did Nitesh Tiwari take 6.5 years to create the battle sequenceRamayana: Rise of a Legend, directed by Nitesh Tiwari, premiered on November 5 and received positive responses. The film features performan...- Pills are paying off! Pharma stocks lead 2026 rally with up to 112% returnIn 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic dem...
- Stocks in news: BSE, Lenskart, Nykaa, Bharti Airtel, LIC, Aurobindo Pharma and NalcoIndian equity markets have enjoyed a remarkable stretch, registering gains for five consecutive sessions. The Nifty 50 index showed impress...
- Zydus Lifesciences among 6 stocks showing White Marubozu patternSix Nifty500 stocks featured in StockEdge's White Marubozu bullish scanner on October 30, signalling strong upward price momentum during th...
- University of Liverpool opens Bengaluru campus with nearly 300 studentsThe University of Liverpool proudly inaugurates its Bengaluru campus, enrolling nearly 300 students across a range of programs. Marking its...
- Jefferies lists 6 factors that will shape CRDMO winners; Divi’s Labs, Sai Life, Laurus, Anthem among stocks to watchIndia's CRDMO sector is on the brink of expansion, backed by solid partnerships with major pharmaceutical players and comprehensive capabil...
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
- Goldman Sachs’ India Portfolio; 10 stocks rally up to 130% in CY26Despite the overall decline, 10 stocks delivered gains ranging from 20% to 130% during the period. CMR Green Technologies was a newly added...
- Retail investors raise stakes in 10 stocks for two straight quarters; shares rally up to 80% in CY26Retail investors increased their holdings in 98 BSE 500 companies for the second consecutive quarter through June 2026, signalling continue...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities plunged nearly 1% before recovering, as escalating US-Iran tensions, soaring crude prices and global bond stress battered s...
- Sai Life Sciences shares drop 4% as TPG Asia likely offloads Rs 2,811 cr worth shares via block dealSai Life Sciences' shares experienced a 4% drop following a significant trade involving 3.2 crore shares. TPG Asia likely divested a 15.4% ...
- Stock Radar: Sai Life Sciences rallies over 20% in 3 months to hit record highs in July; time to buy or book profits?Sai Life Sciences has surged over 20% in the past three months, reaching a new high in July 2025. Technical indicators suggest continued bu...
- Sai Life Sciences shares jump 16% post listing. Should you buy, sell or hold?Sai Life Sciences Share Price: Sai Life Sciences shares surged 16% to Rs 764.4 on their BSE debut, opening at a premium of 18% over the IPO...
- Sai Life Sciences shares list at 18% premium over IPO priceSai Life Sciences shares debuted with a premium on NSE and BSE, exceeding market expectations. The IPO saw strong demand from institutional...
- Sai Life Sciences IPO Day 3: Issue subscribed 10.26 times at close. Check GMP, allotment and listing dateSai Life Sciences' Rs 3,042 crore IPO was oversubscribed 10.26 times at close, driven by institutional investors. The IPO, priced at Rs 522...
- Sai Life Sciences IPO subscribed 1.25 times on Day 2. Check key dates, price band, GMP, and reviewSai Life Sciences IPO: Sai Life Sciences' IPO saw full subscription on its second day, with a 1.25 times oversubscription. Retail investors...
- Sai Life Sciences IPO Day 1: Issue subscribed 84% led by QIBs. Check GMP, other key detailsThe IPO of the contract research and manufacturing firm opened for subscription on Wednesday, achieving 84% overall subscription on the fir...
- Sai Life Sciences IPO opens tomorrow. Check latest GMP, price band, key datesSai Life Sciences' unlisted shares traded at Rs 577 on Tuesday in the grey market, indicating a 5.1% premium over the IPO price band’s uppe...
- Sai Life Sciences IPO opens this week. GMP, price band, key dates among 10 things to knowSai Life Sciences' IPO, aiming to raise up to Rs 3,042 crore, includes a fresh equity issue of up to Rs 950 crore and an Offer for Sale of ...
- Sai Life Sciences files draft papers for nearly Rs 5,000 crore IPOThe company plans to raise funds through an offer of equity shares (face value Re 1 each) through initial public offerings. The offer compr...
Load More
